In Practise Logo
In Practise Logo - Blue
In Practise Logo
Partner Interview
Published February 2, 2026

DCC Plc: German Energy Market & Environmental Legislation

Executive Bio

Executive Profile Hidden

Summary

Subscribe to access hundreds of interviews and primary research

Or contact sales for full access

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

Yes, very interesting. Just to understand, you mentioned we're moving towards using a purified form of propane as a refrigerant. That's like a commodity, an unpatented product. Are the products they're selling today patented, or what makes that not a commodity business as it is today?

Maybe it's because there are only two major manufacturers in the refrigerant business with patents. The companies are DuPont, which spun off a company called Chemours due to pollution issues around their plants in the U.S. The other manufacturer with patents is Honeywell. At TEGA, we were always patent protected by Honeywell and Chemours. We learned later that, for example, TEGA served the southern part of Germany with patented products, while a competitor, Westfalen, served the product supply in the northern part of Germany.

This is a snippet of the transcript.to get full access.

Yes, very interesting. Just to understand, you mentioned we're moving towards using a purified form of propane as a refrigerant. That's like a commodity, an unpatented product. Are the products they're selling today patented, or what makes that not a commodity business as it is today?

No one else could get Chemours or Honeywell products except TEGA and Westfalen. It was a profitable business because smaller traders and customers had to purchase from us. For example, heat pump OEMs had no choice but to buy from TEGA or risk. We had some protection, but things changed a few years later. Chemours and even Honeywell started direct business with smaller OEMs and producers, which affected us. However, the HFO patents are still with Chemours and Honeywell, and they remain their cash cows. They will do everything to protect HFOs in Europe and worldwide, counteracting any legislation that tries to ban these fluorine molecules. HFOs are their only future technology because larger fluorine molecules are not in gas form.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.